| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
45,547 |
35,494 |
$2.24M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
13,764 |
10,649 |
$1.06M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
6,453 |
4,929 |
$490K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
5,365 |
4,442 |
$365K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
6,746 |
5,615 |
$342K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
3,504 |
3,086 |
$262K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,381 |
2,003 |
$195K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
11,433 |
9,199 |
$177K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
5,566 |
4,541 |
$170K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
480 |
439 |
$163K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
8,770 |
7,335 |
$137K |
| 96127 |
|
5,786 |
4,916 |
$83K |
| 99381 |
|
915 |
859 |
$79K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
3,166 |
2,830 |
$73K |
| 90670 |
|
4,048 |
3,143 |
$65K |
| 83655 |
|
4,641 |
3,286 |
$54K |
| 90677 |
|
654 |
578 |
$38K |
| 99173 |
|
4,795 |
4,437 |
$36K |
| Q3014 |
Telehealth originating site facility fee |
1,360 |
1,054 |
$33K |
| 90633 |
|
2,893 |
2,294 |
$32K |
| 90681 |
|
2,495 |
1,971 |
$32K |
| 90648 |
|
3,311 |
2,571 |
$28K |
| 90710 |
|
2,063 |
1,620 |
$27K |
| 36416 |
|
6,639 |
5,127 |
$27K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
587 |
177 |
$25K |
| 90697 |
|
1,303 |
1,092 |
$20K |
| 90723 |
|
2,062 |
1,666 |
$18K |
| 85018 |
|
7,540 |
5,740 |
$17K |
| 90734 |
|
1,098 |
894 |
$17K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,115 |
937 |
$13K |
| 90700 |
|
951 |
710 |
$10K |
| 90686 |
|
1,066 |
898 |
$10K |
| 90696 |
|
771 |
623 |
$10K |
| 36415 |
Collection of venous blood by venipuncture |
1,890 |
1,707 |
$9K |
| 99406 |
|
1,092 |
903 |
$8K |
| 86328 |
|
137 |
97 |
$6K |
| 90715 |
|
475 |
396 |
$6K |
| 96160 |
|
693 |
438 |
$5K |
| 90716 |
|
242 |
176 |
$5K |
| 92551 |
|
311 |
291 |
$5K |
| 99407 |
|
312 |
216 |
$5K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
470 |
257 |
$5K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
171 |
151 |
$4K |
| 90651 |
|
228 |
183 |
$4K |
| 90707 |
|
251 |
182 |
$4K |
| 90620 |
|
251 |
185 |
$4K |
| 99383 |
|
18 |
15 |
$2K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
20 |
12 |
$2K |
| 90647 |
|
121 |
86 |
$1K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
14 |
14 |
$1K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
24 |
22 |
$847.92 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
356 |
199 |
$389.00 |
| 99421 |
|
21 |
19 |
$276.99 |
| 81003 |
|
112 |
100 |
$244.16 |
| 95117 |
|
21 |
12 |
$174.30 |
| 90685 |
|
18 |
15 |
$137.01 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
13 |
12 |
$4.03 |
| 1159F |
|
21,479 |
16,548 |
$0.39 |
| 1160F |
|
21,704 |
16,741 |
$0.38 |
| 0545F |
|
127 |
97 |
$0.00 |
| 4045F |
|
739 |
577 |
$0.00 |
| 3080F |
|
781 |
643 |
$0.00 |
| 4000F |
|
665 |
572 |
$0.00 |
| 3079F |
|
783 |
644 |
$0.00 |
| 3352F |
|
440 |
315 |
$0.00 |
| 2000F |
|
787 |
648 |
$0.00 |
| 1220F |
|
1,157 |
909 |
$0.00 |
| 3075F |
|
781 |
644 |
$0.00 |
| 3074F |
|
784 |
645 |
$0.00 |
| 3353F |
|
315 |
220 |
$0.00 |
| 1036F |
|
315 |
221 |
$0.00 |
| 3351F |
|
440 |
316 |
$0.00 |
| 4063F |
|
127 |
97 |
$0.00 |
| 4060F |
|
314 |
219 |
$0.00 |
| 1035F |
|
314 |
220 |
$0.00 |
| 3354F |
|
441 |
317 |
$0.00 |
| 1000F |
|
127 |
69 |
$0.00 |
| 2060F |
|
440 |
315 |
$0.00 |
| 3085F |
|
1,168 |
946 |
$0.00 |
| 4001F |
|
666 |
573 |
$0.00 |
| 3210F |
|
2,687 |
2,222 |
$0.00 |
| 1033F |
|
1,048 |
856 |
$0.00 |
| 3725F |
|
614 |
486 |
$0.00 |
| 4274F |
|
403 |
343 |
$0.00 |
| 99072 |
|
71 |
50 |
$0.00 |
| 3077F |
|
781 |
642 |
$0.00 |
| 3078F |
|
781 |
644 |
$0.00 |
| 1040F |
|
315 |
220 |
$0.00 |
| 4004F |
|
541 |
417 |
$0.00 |
| 4062F |
|
441 |
316 |
$0.00 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
30 |
12 |
$0.00 |